{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:59:28Z","timestamp":1786993168439,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpedsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Surgery"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jpedsurg.2016.04.021","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T15:30:25Z","timestamp":1464708625000},"page":"1807-1811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Benefit of early inflow exclusion during living donor liver transplantation for unresectable hepatoblastoma"],"prefix":"10.1016","volume":"51","author":[{"given":"Hajime","family":"Uchida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinari","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanobu","family":"Shigeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Nosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidyadhar Padmakar","family":"Mali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seisuke","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mureo","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0005","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/cncr.10282","article-title":"Surgical view of the treatment of patients with hepatoblastoma: Results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group","volume":"94","author":"Schnater","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0010","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","article-title":"Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma","volume":"361","author":"Perilongo","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0015","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/pbc.24220","article-title":"Surgical treatment of hepatoblastoma","volume":"59","author":"Meyers","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0020","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1200\/JCO.2009.22.4857","article-title":"Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: Final results of the SIOPEL-3HR study","volume":"28","author":"Zsiros","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0025","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/pbc.23301","article-title":"Initial liver transplantation for unresectable hepatoblastoma after chemotherapy","volume":"57","author":"Hery","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0030","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1399-3046.2010.01395.x","article-title":"PLUTO first report","volume":"14","author":"Otte","year":"2010","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-0030-1262798","article-title":"High-risk hepatoblastoma: Results in a pediatric liver transplantation center","volume":"21","author":"Barrena","year":"2011","journal-title":"Eur J Pediatr Surg"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/lt.23803","article-title":"Nationwide survey of the outcomes of living donor liver transplantation for hepatoblastoma in Japan","volume":"20","author":"Sakamoto","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00383-002-0906-0","article-title":"Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma","volume":"19","author":"Matsunaga","year":"2003","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0050","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1111\/j.1600-6143.2005.01003.x","article-title":"Living-donor liver transplantation for hepatoblastoma","volume":"5","author":"Kasahara","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0055","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1002\/lt.20044","article-title":"The surgical approach to HCC: Our progress and results in Japan","volume":"10","author":"Makuuchi","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0060","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/SLA.0b013e31819ed22f","article-title":"Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma","volume":"249","author":"Katz","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0022-4804(90)90116-J","article-title":"Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasis","volume":"49","author":"Nishizaki","year":"1990","journal-title":"J Surg Res"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0070","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/00000658-199712000-00007","article-title":"Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study","volume":"226","author":"Man","year":"1997","journal-title":"Ann Surg"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0075","first-page":"180","article-title":"Temporary end to side portacaval shunt in orthotopic hepatic transplantation in humans","volume":"176","author":"Tzakis","year":"1993","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0080","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/lt.21603","article-title":"Temporary portocaval shunt in orthotopic liver transplantation: Need for a standardized approach?","volume":"14","author":"Davila","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0085","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/sj.ki.5000216","article-title":"Risk factors of acute renal failure after liver transplantation","volume":"69","author":"Cabezuelo","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0090","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/lt.20196","article-title":"Acute renal failure after liver transplantation: The role of dopamine and fenoldopam","volume":"10","author":"Leung","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0095","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/jlts.2001.27870","article-title":"Temporary portocaval shunt during liver transplantation with vena cava preservation. Results of a prospective randomized study","volume":"7","author":"Figueras","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00383-010-2708-0","article-title":"Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: Report from the JPLT","volume":"27","author":"Hishiki","year":"2011","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1470-2045(00)00018-8","article-title":"SIOPEL trials using preoperative chemotherapy in hepatoblastoma","volume":"1","author":"Perilongo","year":"2000","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0110","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","article-title":"Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): A prospective, single-arm, feasibility study","volume":"14","author":"Zsiros","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0115","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.ejca.2012.06.023","article-title":"Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma \u2013 a phase II trial of the childhood liver tumour strategy group (SIOPEL)","volume":"48","author":"Zsiros","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0120","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/pbc.22408","article-title":"Irinotecan as maintenance therapy in high-risk hepatoblastoma","volume":"54","author":"Qayed","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0125","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/lt.21586","article-title":"Liver transplantation for hepatoblastoma","volume":"14","author":"Faraj","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1034\/j.1399-3046.2003.00040.x","article-title":"Renal function following liver transplantation for unresectable hepatoblastoma","volume":"7","author":"Lee","year":"2003","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3476(05)83372-4","article-title":"Partial reversibility of cisplatin nephrotoxicity in children","volume":"118","author":"Brock","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0140","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0022-3476(85)80098-6","article-title":"Renal toxicity of cisplatin in children","volume":"106","author":"Womer","year":"1985","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0145","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/sj.clpt.6100513","article-title":"Renal function as a predictor of irinotecan-induced neutropenia","volume":"84","author":"de Jong","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/dmd.110.035451","article-title":"Delayed elimination of SN-38 in cancer patients with severe renal failure","volume":"39","author":"Fujita","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0155","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/FPC.0b013e328014341f","article-title":"Irinotecan pharmacokinetics\/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: Roles of UGT1A1*6 and *28","volume":"17","author":"Minami","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0160","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/jama.2011.749","article-title":"Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: A systematic review and meta-analysis","volume":"305","author":"Biagi","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0165","first-page":"627","article-title":"Surgical treatment and adjuvant chemotherapy in hepatocellular carcinoma patients with advanced vascular involvement","volume":"55","author":"Nanashima","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/pbc.10376","article-title":"Liver transplantation for hepatoblastoma: Results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience","volume":"42","author":"Otte","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0175","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jpedsurg.2008.05.031","article-title":"Survival after liver transplantation for hepatoblastoma: A 2-center experience","volume":"43","author":"Browne","year":"2008","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpedsurg.2016.04.021_bb0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MOP.0000000000000042","article-title":"Hepatoblastoma state of the art: Pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation","volume":"26","author":"Meyers","year":"2014","journal-title":"Curr Opin Pediatr"}],"container-title":["Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346816300987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346816300987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T06:55:12Z","timestamp":1600671312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022346816300987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0022346816300987"],"URL":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2016.04.021","relation":{},"ISSN":["0022-3468"],"issn-type":[{"value":"0022-3468","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benefit of early inflow exclusion during living donor liver transplantation for unresectable hepatoblastoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2016.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}